NCT01103102View on ClinicalTrials.gov

Dose-Response Study of Iocide Oral Rinse

PHASE2CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

April 30, 2012

Conditions
Gingivitis
Interventions
DRUG

Iocide Oral Rinse

Oral Rinse; dosages vary by treatment group; once to twice daily use (depending on treatment group); 12 weeks duration

DRUG

Placebo

Placebo

Trial Locations (1)

78229

University of Texas Health Science Center at San Antonio, San Antonio

Sponsors
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

University of Texas

OTHER

lead

Biomedical Development Corporation

INDUSTRY